Bicycle Therapeutics PLC (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Bicycle Therapeutics Plc - ADR: Is Infosys Ltd. worth buying?
Item: Bicycle Therapeutics Plc - ADR
Rating: 1.31483325
Author: Trendlyne DVM scores

about

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural ge...

6.99 0.05 (0.72%)

54.70% Fall from 52W High

96,481

XNAS Volume

XNAS 24 Dec, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

19.8 / 100

Technically Bearish

32.8 / 100

1Yr Price target upside is 208%

10 analysts

Bicycle Therapeutics PLC (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bicycle Therapeutics PLC (ADR) Live Stock Price Today, Share Analysis and Chart

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural ge...

54.70% Fall from 52W High

SWOT Analysis

Bicycle Therapeutics PLC (ADR) Live Price Chart